In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

“Targeting meningeal Tregs could open new avenues for interventions in conditions such as multiple sclerosis, neurodegeneration, and cognitive decline.” To Costantino Iadecola of Weill Cornell Medical ...

A collection of short films for primary schools, exploring the experiences and contributions of people from communities across the UK, and celebrating the rich contribution of the black community ...

Identifying the seven continents, five oceans, the Equator, the Northern and Southern Hemisphere and the North and South Pole. and The Arctic Ocean. I orbit around the sun. Not that fast! It ...

Myelin – produced by Schwann cells in the periphery and oligodendrocytes in the CNS – is defective in diseases such as multiple sclerosis, and many myelin repair strategies aim to mitigate ...

Neurodegeneration refers to the progressive atrophy and loss of function of neurons, which is present in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Improved ...

Multiple sclerosis (MS) is a debilitating neurodegenerative disease ... relationship dissatisfaction was an additional factor influencing his overall health. His primary care physician prescribed ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block ... Ocrelizumab is an infusion medication that treats CIS, relapsing-remitting MS, and primary ...

In most cases, the diagnosis of multiple sclerosis (MS) presents few difficulties. Clinical evidence of lesions disseminated in time and space, backed up by magnetic resonance imaging (MRI) and/or ...